Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Cited In for PubMed (Select 11414546)


Avoidance as expectancy in rats: sex and strain differences in acquisition.

Avcu P, Jiao X, Myers CE, Beck KD, Pang KC, Servatius RJ.

Front Behav Neurosci. 2014 Oct 6;8:334. doi: 10.3389/fnbeh.2014.00334. eCollection 2014.


Long working hours and subsequent use of psychotropic medicine: a study protocol.

Hannerz H, Albertsen K.

JMIR Res Protoc. 2014 Sep 19;3(3):e51. doi: 10.2196/resprot.3301.


A case of anxiety associated with miliary tuberculosis.

Alosaimi FD, Alkharboush FA, Altuwariqi MH.

Int Med Case Rep J. 2014 Jun 20;7:111-5. doi: 10.2147/IMCRJ.S64855. eCollection 2014.


Prevalence of anxiety disorders among Finnish primary care high utilizers and validation of Finnish translation of GAD-7 and GAD-2 screening tools.

Kujanpää T, Ylisaukko-Oja T, Jokelainen J, Hirsikangas S, Kanste O, Kyngäs H, Timonen M.

Scand J Prim Health Care. 2014 Jun;32(2):78-83. doi: 10.3109/02813432.2014.920597. Epub 2014 Jun 12.


Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomes.

Markell HM, Newman MG, Gallop R, Gibbons MB, Rickels K, Crits-Christoph P.

Behav Ther. 2014 Jul;45(4):495-506. doi: 10.1016/j.beth.2014.02.008. Epub 2014 Feb 24.


The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review.

Haller H, Cramer H, Lauche R, Gass F, Dobos GJ.

BMC Psychiatry. 2014 May 1;14:128. doi: 10.1186/1471-244X-14-128.


Behaviourally inhibited temperament and female sex, two vulnerability factors for anxiety disorders, facilitate conditioned avoidance (also) in humans.

Sheynin J, Beck KD, Pang KC, Servatius RJ, Shikari S, Ostovich J, Myers CE.

Behav Processes. 2014 Mar;103:228-35. doi: 10.1016/j.beproc.2014.01.003. Epub 2014 Jan 9.


Prevalence and features of generalized anxiety disorder in Department of Veteran Affairs primary care settings.

Milanak ME, Gros DF, Magruder KM, Brawman-Mintzer O, Frueh BC.

Psychiatry Res. 2013 Sep 30;209(2):173-9. doi: 10.1016/j.psychres.2013.03.031. Epub 2013 May 7.


Current diagnosis and treatment of anxiety disorders.

Bystritsky A, Khalsa SS, Cameron ME, Schiffman J.

P T. 2013 Jan;38(1):30-57.


Anxioselective anxiolytics: on a quest for the Holy Grail.

Skolnick P.

Trends Pharmacol Sci. 2012 Nov;33(11):611-20. doi: 10.1016/ Epub 2012 Sep 14. Review.


Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model.

Sedláčková N, Ponechalová V, Ujházy E, Dubovický M, Mach M.

Interdiscip Toxicol. 2011 Dec;4(4):211-5. doi: 10.2478/v10102-011-0032-8.


Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.

Frye CA, Paris JJ, Walf AA, Rusconi JC.

Front Neurosci. 2012 Jan 19;5:136. doi: 10.3389/fnins.2011.00136. eCollection 2011.


MRI studies in late-life mood disorders.

Andreescu C, Aizenstein H.

Curr Top Behav Neurosci. 2012;11:269-87. doi: 10.1007/7854_2011_175. Review.


The epidemiology of anxiety disorders: a review.

Martin P.

Dialogues Clin Neurosci. 2003 Sep;5(3):281-98.


Interpersonal pathoplasticity in individuals with generalized anxiety disorder.

Przeworski A, Newman MG, Pincus AL, Kasoff MB, Yamasaki AS, Castonguay LG, Berlin KS.

J Abnorm Psychol. 2011 May;120(2):286-98. doi: 10.1037/a0023334.


Altered cerebral blood flow patterns associated with pathologic worry in the elderly.

Andreescu C, Gross JJ, Lenze E, Edelman KD, Snyder S, Tanase C, Aizenstein H.

Depress Anxiety. 2011 Mar;28(3):202-9. doi: 10.1002/da.20799.


Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

Davidson JR, Feltner DE, Dugar A.

Prim Care Companion J Clin Psychiatry. 2010;12(2). pii: PCC.09r00772. doi: 10.4088/PCC.09r00772blu.


Recognizing and managing anxiety disorders in primary health care in Turkey.

Kartal M, Coskun O, Dilbaz N.

BMC Fam Pract. 2010 Apr 28;11:30. doi: 10.1186/1471-2296-11-30.


Menstrual cycle-related exacerbation of disease.

Pinkerton JV, Guico-Pabia CJ, Taylor HS.

Am J Obstet Gynecol. 2010 Mar;202(3):221-31. doi: 10.1016/j.ajog.2009.07.061. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk